Acute Cholecystitis Management: When to Operate, When to Drain, and When to Wait
Clinical Practice Update — Diagnosis, Severity Grading, Timing of Cholecystectomy, and Alternatives for High-Risk Patients
This is an original clinical education article informed by current guidelines and evidence. See References below for source documents.
- Clinical Focus
- Diagnosis, severity classification, operative timing, laparoscopic technique, bail-out procedures, and management of high-risk patients with acute cholecystitis
- Target Audience
- General surgeons, acute care surgery teams, emergency physicians, surgical residents, hepatobiliary surgeons
- Setting
- Emergency departments, acute surgical units, operating theatres, interventional radiology suites
- Source Evidence
- •Tokyo Guidelines 2018 (TG18) — Management of Acute Cholecystitis (J Hepatobiliary Pancreat Sci, 2018)
- •WSES 2020 Guidelines on Acute Calculous Cholecystitis (World J Emerg Surg, 2020)
- •ACDC Trial — Early Laparoscopic Cholecystectomy vs Conservative Treatment (Ann Surg, 2013)
- •CHOCOLATE Trial — Cholecystectomy vs Cholecystostomy for Acute Cholecystitis in High-Risk Patients (BMJ, 2018)
- •SAGES Safe Cholecystectomy Programme — Critical View of Safety (2014, updated)
Key Clinical Takeaways
The most important actionable points from this Practice Update on acute cholecystitis management. Each links to the detailed discussion below.
- 1Grade every case of acute cholecystitis as mild (Grade I), moderate (Grade II), or severe (Grade III) at the point of diagnosis — this drives the entire management plan → Grading Severity
- 2Perform early laparoscopic cholecystectomy within 72 hours of symptom onset for Grade I and Grade II disease — delaying increases difficulty and does not reduce complications → When to Operate
- 3Achieve the Critical View of Safety before clipping or dividing any ductal structure — this is the single most important step in preventing bile duct injury → Safe Surgical Technique
- 4Have a bail-out strategy ready before starting — subtotal cholecystectomy is a safe and underused alternative to forcing a dangerous dissection → Safe Surgical Technique
- 5For Grade III disease with organ dysfunction, stabilise first with antibiotics and percutaneous cholecystostomy — operate only after the patient has been optimised → Managing the High-Risk Patient
- 6Percutaneous cholecystostomy is a bridge, not a destination — plan for definitive cholecystectomy once the patient has recovered → Managing the High-Risk Patient
- 7Do not send patients home with a plan for interval cholecystectomy after a first episode if they can safely undergo surgery during the index admission — readmission rates are unacceptably high → When to Operate
- 8Start antibiotics targeting Gram-negatives and anaerobes for Grade II and III disease — antibiotics alone are insufficient for Grade I cases where surgery is the definitive treatment → Antibiotic Therapy
- 9Ultrasound is the first-line imaging for diagnosis — CT is not needed routinely but is valuable when ultrasound is equivocal or complications are suspected → Making the Diagnosis
- 10Assess for concomitant choledocholithiasis using liver function tests and ultrasound — manage CBD stones before or during cholecystectomy, not after → Concomitant CBD Stones
How Should You Confirm the Diagnosis?
The TG18 diagnostic criteria for acute cholecystitis combine local signs of inflammation, systemic signs of infection, and confirmatory imaging findings. Meeting criteria from at least two of these three categories, with imaging confirmation, establishes the diagnosis. In practice, the combination of right upper quadrant tenderness with a positive Murphy sign, elevated inflammatory markers, and ultrasound findings of gallbladder wall thickening or pericholecystic fluid is sufficient to proceed.
Perform right upper quadrant ultrasound as the first-line imaging investigation for all patients with suspected acute cholecystitis. Look for gallstones, gallbladder wall thickening greater than 4 mm, pericholecystic fluid, and a sonographic Murphy sign. Ultrasound has a sensitivity exceeding 80% and specificity exceeding 80% for acute cholecystitis when multiple features are present.
Strong Rec High Evidence TG18 WSES 2020Obtain a CT abdomen when ultrasound is equivocal, when gangrenous or emphysematous cholecystitis is suspected, or when you need to evaluate for complications such as perforation or abscess. CT is also more reliable in obese patients and when the gallbladder is not well visualised on ultrasound.
Moderate Rec Moderate Evidence TG18Obtain liver function tests including bilirubin, ALP, GGT, and transaminases on every patient with suspected acute cholecystitis. These are essential for assessing the likelihood of concomitant common bile duct stones and for severity grading (hepatic dysfunction is a Grade III criterion).
Strong Rec Moderate Evidence TG18 WSES 2020How Should You Grade Severity and Why Does It Matter?
The TG18 severity grading system divides acute cholecystitis into three grades that directly determine management strategy. Grade I patients should proceed to early cholecystectomy. Grade II patients should also have early surgery if the surgical team is experienced and the patient can tolerate it, but may need staged management if the local inflammation is particularly severe. Grade III patients need organ support and source control before any consideration of definitive surgery.
Perform severity grading at the point of diagnosis using the TG18 criteria. Grade I (mild) is acute cholecystitis in an otherwise healthy patient without organ dysfunction or severe local inflammation. Grade II (moderate) is associated with elevated WBC above 18,000, a palpable mass, symptom duration beyond 72 hours, or marked local complications. Grade III (severe) involves organ dysfunction.
Strong Rec Moderate Evidence TG18Acute Cholecystitis Severity: What Each Grade Means for Your Management Plan
| Grade | Key Clinical Features | Recommended Management | Timing | Common Pitfalls |
|---|---|---|---|---|
| Grade I (Mild) | Otherwise healthy, no organ dysfunction, mild local inflammation | Early laparoscopic cholecystectomy. Antibiotics are optional — used primarily as preoperative prophylaxis. | Within 72 hours of symptom onset; ideally during the index admission | Discharging with a plan for interval surgery — up to one in three will experience gallstone-related complications or readmission before their planned operation date |
| Grade II (Moderate) | WBC >18,000, palpable RUQ mass, symptoms >72 hours, local complications (pericholecystic abscess, hepatic abscess, biliary peritonitis, gangrenous or emphysematous changes) | Early cholecystectomy by an experienced surgeon if possible. If local conditions are severely hostile, IV antibiotics and gallbladder drainage, then delayed surgery. | Early if expertise available; otherwise staged with initial drainage | Persisting with a dangerous dissection rather than converting to subtotal cholecystectomy or placing a tube cholecystostomy |
| Grade III (Severe) | Any organ dysfunction: cardiovascular (hypotension requiring vasopressors), neurological (altered consciousness), respiratory (PaO2/FiO2 <300), renal (oliguria/creatinine >2 mg/dL), hepatic (INR >1.5), haematological (platelets <100,000) | Organ support, IV antibiotics, and percutaneous cholecystostomy. Definitive cholecystectomy deferred until patient is medically optimised. | Drain urgently; operate only after recovery | Attempting cholecystectomy on a septic, unstable patient with organ failure — the operative mortality in this group is prohibitively high |
- Severity may change — reassess if the patient deteriorates after initial grading.
- The CCI (Charlson Comorbidity Index) and ASA score should be assessed alongside TG18 grading to judge fitness for surgery.
When Should You Perform Cholecystectomy?
The debate over early versus delayed cholecystectomy for acute cholecystitis has been definitively settled. Multiple randomised trials, including the ACDC trial, consistently show that early laparoscopic cholecystectomy performed within 72 hours of symptom onset is safe, reduces total hospital stay, does not increase complication rates, and eliminates the risk of gallstone-related readmissions during the waiting period.
Perform laparoscopic cholecystectomy within 72 hours of symptom onset for Grade I (mild) acute cholecystitis. Early surgery during the index admission is the standard of care. Delaying to an interval procedure increases the total number of hospital days, exposes the patient to a significant risk of recurrent symptoms or complications while waiting (reported at 20–35% across trials), and does not reduce operative difficulty.
Strong Rec High Evidence TG18 WSES 2020 ACDC 2013Perform early laparoscopic cholecystectomy for Grade II (moderate) acute cholecystitis when an experienced laparoscopic surgeon is available. The local inflammation is more challenging, but outcomes are acceptable when operated on early by surgeons comfortable with difficult gallbladder surgery and bail-out procedures.
Strong Rec Moderate Evidence TG18 WSES 2020Do not routinely delay cholecystectomy to an interval procedure for patients with Grade I or II disease who are fit for surgery. If early surgery is not possible during the index admission due to resource constraints, schedule cholecystectomy within 2 weeks rather than the traditional 6–8 weeks.
Strong Rec High Evidence WSES 2020How Should You Operate Safely on an Inflamed Gallbladder?
Bile duct injury is the most feared complication of cholecystectomy, and the inflamed gallbladder is where it happens most often. The key to safe surgery is a systematic approach: achieve the Critical View of Safety, know when to bail out, and never clip a structure you cannot definitively identify.
Achieve the Critical View of Safety (CVS) before clipping or dividing any structure in the hepatocystic triangle. The three criteria of CVS are: the hepatocystic triangle is cleared of fat and fibrous tissue, the lower third of the gallbladder is separated from the liver bed, and only two structures (cystic duct and cystic artery) are seen entering the gallbladder. If CVS cannot be achieved, do not proceed with standard cholecystectomy — employ a bail-out strategy.
Strong Rec Moderate Evidence SAGES 2014 TG18Perform a subtotal (partial) cholecystectomy when the Critical View of Safety cannot be achieved and the dissection in Calot's triangle is unsafe. Leave the posterior wall of the gallbladder attached to the liver bed (reconstituting or fenestrating subtotal technique). This is not a failure — it is a deliberate, safe decision that protects the bile duct.
Strong Rec Moderate Evidence SAGES 2014 WSES 2020Consider fundus-first (top-down) dissection when the hepatocystic triangle is frozen. Starting from the fundus and working downward can help define the anatomy in severely inflamed cases. If even this approach does not clarify the anatomy, convert to subtotal cholecystectomy.
Moderate Rec Low Evidence SAGES 2014Do not convert to open surgery solely because the case is difficult laparoscopically. Conversion should be reserved for situations where laparoscopic visualisation is truly inadequate, there is uncontrolled bleeding, or there is a suspected bile duct injury requiring open repair. A laparoscopic subtotal cholecystectomy is preferable to an open total cholecystectomy with bile duct injury risk.
Moderate Rec Low Evidence SAGES 2014Bail-Out Strategies: What to Do When the Dissection Becomes Unsafe
| When You Encounter This | Consider This Strategy | Key Advantage | Practical Tip |
|---|---|---|---|
| Frozen Calot's triangle — CVS not achievable | Subtotal (reconstituting) cholecystectomy — divide GB at the infundibulum, leave posterior wall on liver | Avoids the bile duct entirely; can be done laparoscopically | Cauterise the remnant mucosa to reduce biliary leak risk. Place a drain near the stump. |
| Severe adhesions obscuring all anatomy | Subtotal (fenestrating) cholecystectomy — open the GB, remove stones, leave the posterior wall, suture or staple the remnant | Achieves source control with minimal dissection in the danger zone | Ensure the cystic duct stump opening is closed or a drain is placed. Expect some bile drainage for a few days. |
| Unstable patient or extremely hostile abdomen intraoperatively | Cholecystostomy tube — open the fundus, remove stones, place a Foley catheter, secure to skin | Rapid source control; minimal operative time | Plan for definitive cholecystectomy at 6–8 weeks once the patient has recovered. |
| Suspected bile duct injury during dissection | Stop, irrigate, identify — intraoperative cholangiogram if possible; consult hepatobiliary surgeon | Early recognition and expert repair dramatically improve outcomes | Never attempt primary bile duct repair unless you have hepatobiliary expertise. Place a drain and refer. |
What Should You Do When the Patient Is Too Sick for Surgery?
Perform percutaneous cholecystostomy as a temporising measure for Grade III (severe) acute cholecystitis in patients who are unfit for general anaesthesia and surgery. This achieves gallbladder drainage and source control without the physiological insult of an operation. Arrange the tube under ultrasound or CT guidance by interventional radiology.
Strong Rec Moderate Evidence TG18Plan for definitive cholecystectomy after percutaneous cholecystostomy once the patient has recovered from the acute illness and been medically optimised. The cholecystostomy tube is a bridge to surgery, not a permanent solution. Patients left with a tube in situ indefinitely face ongoing risks of tube dislodgement, site infection, and recurrent cholecystitis when the tube blocks.
Strong Rec Low Evidence TG18 CHOCOLATE 2018Which Antibiotics Should You Use?
Prescribe empiric IV antibiotics covering Gram-negative enteric organisms and anaerobes for Grade II and Grade III acute cholecystitis. First-line options include piperacillin-tazobactam, or a cephalosporin plus metronidazole. Tailor therapy to local resistance patterns and de-escalate based on culture results when available.
Strong Rec Moderate Evidence TG18 WSES 2020Discontinue antibiotics after cholecystectomy for uncomplicated (Grade I) acute cholecystitis. Postoperative antibiotics are not required and should be treated as prophylaxis only. For complicated disease, continue antibiotics for a total of 3–5 days postoperatively depending on the degree of contamination and clinical response.
Strong Rec Moderate Evidence TG18What About Concomitant Common Bile Duct Stones?
Assess every patient with acute cholecystitis for concomitant choledocholithiasis using liver function tests and ultrasound measurement of the common bile duct. A CBD diameter greater than 8 mm on ultrasound, elevated bilirubin, or raised ALP/GGT should prompt further investigation with MRCP or intraoperative cholangiography.
Strong Rec Moderate Evidence TG18 WSES 2020Manage confirmed CBD stones before or during cholecystectomy — not after. Options include preoperative ERCP followed by cholecystectomy during the same admission, single-stage laparoscopic CBD exploration at the time of cholecystectomy, or intraoperative ERCP. The choice depends on local expertise and resources.
Strong Rec High Evidence TG18Clinical Decision Pathway
A practical, question-based approach to managing an adult presenting with suspected acute cholecystitis.
Evidence in Context
Where the major guidelines and trials converge, where they differ, and what remains uncertain.
Where TG18 and WSES Agree
Both frameworks agree on the centrality of severity grading, the superiority of early laparoscopic cholecystectomy for Grade I and II disease, the role of percutaneous cholecystostomy for Grade III, the importance of the Critical View of Safety, and the legitimacy of subtotal cholecystectomy as a planned bail-out strategy. They also concur that postoperative antibiotics are unnecessary for uncomplicated cases and that CBD stones should be addressed during the index admission.
Where They Differ
Timing flexibility: TG18 emphasises the 72-hour window more strictly, while WSES takes a more pragmatic position that early surgery should be offered during the index admission even beyond 72 hours, as delaying to 6–8 weeks does not improve outcomes and worsens them through readmissions.
Role of cholecystostomy: TG18 gives percutaneous cholecystostomy a prominent role for Grade III patients. WSES is more cautious, noting the CHOCOLATE trial results that suggest cholecystostomy may not be superior to early surgery in patients who can tolerate anaesthesia, even if they are high-risk.
The CHOCOLATE Trial: What It Means for High-Risk Patients
The CHOCOLATE trial randomised high-risk patients (APACHE II score 7–14) with acute cholecystitis to emergency laparoscopic cholecystectomy or percutaneous cholecystostomy. The trial was stopped early because cholecystostomy was not superior and resulted in more major complications and gallstone-related readmissions at one year. The key takeaway: if a high-risk patient can tolerate general anaesthesia at all, early cholecystectomy — even a subtotal one — is likely the better option. Reserve cholecystostomy for patients who genuinely cannot tolerate any surgical procedure.
The ACDC Trial: Settling the Early vs Delayed Debate
The ACDC trial randomised 618 patients with acute cholecystitis to early cholecystectomy (within 24 hours of admission) versus initial conservative treatment with interval cholecystectomy at 7–45 days. Early surgery resulted in significantly fewer complications (11.8% vs 34.4% morbidity), shorter total hospital stay, and no increase in conversion rates or mortality. Meta-analyses including the ACDC data have also confirmed that early surgery does not increase bile duct injury rates. This trial, along with multiple meta-analyses, has made early cholecystectomy the unequivocal standard of care.
What We Still Don't Know
References
- 1.Okamoto K, Suzuki K, Takada T, et al. Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):55–72. doi:10.1002/jhbp.516
- 2.Pisano M, Allievi N, Gurusamy K, et al. 2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis. World J Emerg Surg. 2020;15(1):61. doi:10.1186/s13017-020-00336-x
- 3.Gutt CN, Encke J, Köninger J, et al. Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study). Ann Surg. 2013;258(3):385–393. doi:10.1097/SLA.0b013e3182a1599b
- 4.Loozen CS, van Santvoort HC, van Duijvendijk P, et al. Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): multicentre randomised clinical trial. BMJ. 2018;363:k3965. doi:10.1136/bmj.k3965
- 5.Strasberg SM. A three-step conceptual roadmap for avoiding bile duct injury in laparoscopic cholecystectomy: an invited perspective review. J Hepatobiliary Pancreat Sci. 2019;26(4):123–127. doi:10.1002/jhbp.616
- 6.SAGES Safe Cholecystectomy Task Force. The SAGES Safe Cholecystectomy Program. sages.org/safe-cholecystectomy-program
How to Read the Evidence Tags
Every recommendation carries two tags indicating recommendation strength and evidence quality. These are Medaptly's own simplified interpretations for educational clarity.
Recommendation Strength
| Tag | What It Means | In Practice |
|---|---|---|
| Strong Rec | High-quality evidence broadly supports this action. Benefits clearly outweigh risks. | Standard practice for most patients meeting the criteria. |
| Moderate Rec | Evidence favours this action, though some uncertainty remains. | Most patients should receive this, but context may lead to a different decision. |
| Conditional Rec | Benefit less certain. Depends on patient circumstances. | May be appropriate for some but not all. Use shared decision-making. |
| Against | Evidence shows no benefit, or risks outweigh benefits. | Avoid. Document reasoning if used in exceptional circumstances. |
Evidence Quality
| Tag | What It Means | Confidence Level |
|---|---|---|
| High Evidence | Multiple RCTs or high-quality meta-analyses. | Very confident. Unlikely to change substantially. |
| Moderate Evidence | Single RCT or large observational studies. | Reasonably confident. Direction likely correct. |
| Low Evidence | Expert consensus, small studies, or extrapolated evidence. | Less certain. May change with new evidence. |
These are Medaptly's simplified interpretations for educational clarity. For the full classification systems used by each source guideline, consult the original documents listed in References.